Effect of L-Carnitine Supplementation in Hemodialysis Patients

E Vesela, J Racek, L Trefil, V Jankovy'ch, M Pojer - Nephron, 2001 - karger.com
Abstract Background/Aim: L-Carnitine is important in β-oxidation of fatty acids. A lack of
carnitine in hemodialysis patients is caused by insufficient carnitine synthesis and especially …

[引用][C] Effect of L-Carnitine supplementation in hemodialysis patients

E VESELA, J RACEK, L TREFIL, V JANKOVYCH… - Nephron, 2001 - pascal-francis.inist.fr
Effect of L-Carnitine supplementation in hemodialysis patients CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Effect of L-carnitine supplementation in hemodialysis patients.

E Veselá, J Racek, L Trefil, V Jankových, M Pojer - 2001 - cabidigitallibrary.org
Abstract Background/Aim: L-Carnitine is important in β-oxidation of fatty acids. A lack of
carnitine in haemodialysis patients is caused by insufficient carnitine synthesis and …

Effect of L-Carnitine Supplementation in Hemodialysis Patients

E Veselá, J Racek, L Trefil, V Jankovy'ch, M Pojer - Nephron, 2001 - karger.com
Background/Aim: L-Carnitine is important in β-oxidation of fatty acids. A lack of carnitine in
hemodialysis patients is caused by insufficient carnitine synthesis and especially by its loss …

Effect of L-Carnitine Supplementation in Hemodialysis Patients

E Veselá, J Racek, L Trefil, V Jankovy'ch, M Pojer - Nephron, 2001 - cir.nii.ac.jp
抄録< jats: p> Background/Aim: L-Carnitine is important in β-oxidation of fatty acids. A lack of
carnitine in hemodialysis patients is caused by insufficient carnitine synthesis and especially …

Effect of L-carnitine supplementation in hemodialysis patients.

E Veselá, J Racek, L Trefil, V Jankovy'ch, M Pojer - Nephron, 2001 - europepmc.org
Methods Twelve regularly dialyzed patients (average age 55.5 years, average dialysis
treatment period 22.5 months) were given 15 mg/kg L-carnitine intravenously three times …

Effect of L-carnitine supplementation in hemodialysis patients

E Vesela, J Racek, L Trefil, V Jankovych, M Pojer - Nephron, 2001 - search.proquest.com
BACKGROUND/AIM: L-Carnitine is important in beta-oxidation of fatty acids. A lack of
carnitine in hemodialysis patients is caused by insufficient carnitine synthesis and especially …

Effect of L-carnitine supplementation in hemodialysis patients

E Veselá, J Racek, L Trefil, V Jankovy'ch… - Nephron, 2001 - pubmed.ncbi.nlm.nih.gov
Background/aim L-Carnitine is important in beta-oxidation of fatty acids. A lack of carnitine in
hemodialysis patients is caused by insufficient carnitine synthesis and especially by its loss …

[引用][C] Effect of L-Carnitine supplementation in hemodialysis patients

E VESELA, J RACEK, L TREFIL, V JANKOVYCH… - Nephron, 2001 - Karger